Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases.
Publication
, Journal Article
Patel, DD; Antoni, C; Freedman, SJ; Levesque, MC; Sundy, JS
Published in: J Allergy Clin Immunol
September 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Allergy Clin Immunol
DOI
EISSN
1097-6825
Publication Date
September 2017
Volume
140
Issue
3
Start / End Page
685 / 687
Location
United States
Related Subject Headings
- Research Design
- Immune System Diseases
- Humans
- Drug Development
- Clinical Trials, Phase III as Topic
- Clinical Trials, Phase II as Topic
- Allergy
- 3204 Immunology
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Patel, D. D., Antoni, C., Freedman, S. J., Levesque, M. C., & Sundy, J. S. (2017). Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases. J Allergy Clin Immunol, 140(3), 685–687. https://doi.org/10.1016/j.jaci.2017.04.029
Patel, Dhavalkumar D., Christian Antoni, Steven J. Freedman, Marc C. Levesque, and John S. Sundy. “Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases.” J Allergy Clin Immunol 140, no. 3 (September 2017): 685–87. https://doi.org/10.1016/j.jaci.2017.04.029.
Patel DD, Antoni C, Freedman SJ, Levesque MC, Sundy JS. Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases. J Allergy Clin Immunol. 2017 Sep;140(3):685–7.
Patel, Dhavalkumar D., et al. “Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases.” J Allergy Clin Immunol, vol. 140, no. 3, Sept. 2017, pp. 685–87. Pubmed, doi:10.1016/j.jaci.2017.04.029.
Patel DD, Antoni C, Freedman SJ, Levesque MC, Sundy JS. Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases. J Allergy Clin Immunol. 2017 Sep;140(3):685–687.
Published In
J Allergy Clin Immunol
DOI
EISSN
1097-6825
Publication Date
September 2017
Volume
140
Issue
3
Start / End Page
685 / 687
Location
United States
Related Subject Headings
- Research Design
- Immune System Diseases
- Humans
- Drug Development
- Clinical Trials, Phase III as Topic
- Clinical Trials, Phase II as Topic
- Allergy
- 3204 Immunology
- 1107 Immunology